Learning Chroma\N States from Chip-‐Seq Data

Total Page:16

File Type:pdf, Size:1020Kb

Learning Chroma\N States from Chip-‐Seq Data Learning Chroman States from ChIP-seq data Luca Pinello GC Yuan Lab Outline • Chroman structure, histone modificaons and combinatorial paerns • How to segment the genome in chroman states • How to use ChromHMM step by step • Further references 2 Epigene-cs and chroman structure • All (almost) the cells of our body share the same genome but have very different gene expression programs…. 3 h?p://jpkc.scu.edu.cn/ywwy/zbsw(E)/edetail12.htm The code over the code • The chroman structure and the accessibility are mainly controlled by: 1. Nucleosome posioning, 2. DNA methylaon, 3. Histone modificaons. 4 Histone Modificaons Specific histone modificaons or combinaons of modificaons confer unique biological func-ons to the region of the genome associated with them: • H3K4me3: promoters, gene acva.on • H3K27me3: promoters, poised enhancers, gene silencing • H2AZ: promoters • H3K4me1: enhancers • H3K36me3: transcribed regions • H3K9me3: gene silencing • H3k27ac: acve enhancers 5 Examples of *-Seq Measuring the genome genome fragmentation assembler DNA DNA reads “genome” ChIP-seq to measure histone data fragments Measuring the regulome (e.g., protein-binding of the genome) Chromatin Immunopreciptation genomic (ChIP) + intervals fragmentation Protein - peak caller bound by DNA bound DNA reads proteins REVIEWS fragments a also informative, as this ratio corresponds to the fraction ChIP–chip of nucleosomes with the particular modification at that location, averaged over all the cells assayed. One of the difficulties in conducting a ChIP–seq con- trol experiment is the large amount of sequencing that ChIP–seq may be necessary. For input DNA and bulk nucleosomes, many of the sequenced tags are spread evenly across the genome. To obtain accurate estimates throughout the genome, sufficient numbers of tags are needed at each point; otherwise fold enrichment at the peaks will ChIP–seq input DNA result in large errors due to sampling bias. Therefore, the total number of tags to be sequenced is potentially very large. Alternatively, it is possible to avoid sequencing a control sample if one is only interested in differential binding patterns between conditions or time points and Pros35 CG4908 eEF1 if the variation in chromatin preparations is small. NPC1 CG5708 CG5694 Depth of sequencing. One crucial difference between ChIP–chip and ChIP–seq is that the number of tiling 10,220,000 10,225,000 10,230,000 arrays that is used in a ChIP–chip experiment is fixed b regardless of the protein or modification of interest, CTCF 6 Adapted from Dewey lecture and Peter Park Nature Gene-cs Review whereas the number of fragments that is sequenced in a ChIP–seq experiment is determined by the investiga- tor. In published ChIP–seq experiments, a single lane of the Illumina Genome Analyzer was the basic unit of RNA polymerase II sequencing. When it was introduced, a single lane gen- erated 4–6 million reads before alignment but, owing to improvements in the system, a single lane now gener- ates 8–15 million reads or more. Given the cost of each experiment, many early data sets contained reads from H3K36me3 a single lane regardless of what the specific experiment was. Intuitively, one expects that when a large number of binding sites are present in the genome for a DNA- binding protein or when a histone modification covers a large fraction of the genome, a correspondingly large number of tags will be needed to cover each bound region at the same tag density. One reasonable crite- rion for determining sufficient sequencing depth would H3K27me3 be that the results of a given analysis do not change FBXO7 when more reads are obtained. In terms of the number of binding sites, this criterion translates to the presence of a ‘saturation point’ after which no further binding sites BPIL2 SYN3 are discovered with additional reads. 31,200,000 31,220,000 31,240,000 31,260,000 The issue of saturation points has been examined in a recent paper through simulation studies48. In three Figure 2 | ChIP profiles. a | Examples of the profiles generated byNa chromatinture Revie immunoprews | Genetics- cipitation followed by sequencing (ChIP–seq) or by microarray (ChIP–chip). Shown is a example data sets, a reference set of sites was generated section of the binding profiles of the chromodomain protein Chromator, as measured based on the full set of sequencing reads in each case. by ChIP–chip (unlogged intensity ratio; blue) and ChIP–seq (tag density; red) in the Then, a wide range of different read counts was sampled Drosophila melanogaster S2 cell line. The tag density profile obtained by ChIP–seq from the complete data set, with multiple random selec- reveals specific positions of Chromator binding with higher spatial resolution and tions for each sample size. Binding sites were determined sensitivity. The ChIP–seq input DNA (control experiment) tag density is shown in grey for for each sample with a threshold probability (p value), comparison. b | Examples of different types of ChIP–seq tag density profiles in human T and the results for each sample size were averaged. The cells. Profiles for different types of proteins and histone marks can have different types of fraction of the reference set that was recovered as a func- features, such as: sharp binding sites, as shown for the insulator binding protein CTCF tion of the number of reads is shown in FIG. 3A. If there (CCCTC-binding factor; red); a mixture of shapes, as shown for RNA polymerase II was a saturation point, the number of sites found would (orange), which has a sharp peak followed by a broad region of enrichment; medium size broad peaks, as shown for histone H3 trimethylated at lysine 36 (H3K36me3; green), increase up to a certain point and then plateau, which which is associated with transcription elongation over the gene; or large domains, as would indicate that the rate at which new sites were shown for histone H3 trimethylated at lysine 27 (H3K27me3; blue), which is a repressive being discovered had slowed down to the point where mark that is indicative of Polycomb-mediated silencing. BPIL2, bactericidal/permeability- any further increase in the number of reads would be increasing protein-like 2; FBXO7, F box only 7; NPC1, Niemann-Pick disease, type C1; inefficient at yielding new sites. When the simulation Pros35, proteasome 35 kDa subunit; SYN3, synapsin III. Data for part b are from REF. 25. was performed, however, the results indicated that NATURE REVIEWS | GENETICS VOLUME 10 | OCTOBER 2009 | 673 )''0DXZd`ccXeGlYc`j_\ijC`d`k\[%8cci`^_kji\j\im\[ Figure 1. Generation of Comprehensive A MappedMapped reareadsds TotalTotal bases OP9 coculture -> colony-forming ((billion)billion) ((billion)billion) Epigenome Reference Maps for hESCs and -> colony subculture Mesenchymal Stem Cell (MSC) Four hESC-Derived Lineages 19-22 days CChIP-seqhIP-seq 5.85.8 210 (A) Schematic of hESC differentiation procedures Noggin + SB431542 Neural Progenitor and a summary of the epigenomic data sets pro- hESC (H1) Cell (NPC) 7 days duced in this study. MethylC-SeqMethylC-Seq 5.3 457 BMP4 Trophoblast-like Cell (B) A snapshot of the UCSC genome browser 5 days (TBL) shows the DNA methylation level (mCG/CG), RNA- RRNA-SeqNA-Seq 3.83.8 380 seq reads (+, Watson strand; , Crick strand), FGF2 + BMP4 Mesendoderm À and ChIP-seq reads (RPKM) of 24 chromatin 2 days (ME) marks in H1. We can “call peaks” but… See also Figure S1. B Epigenomic landscape in human embryonic stem cells (H1) chr6:30,614,231-31,337,674,, ,, H2AK5ac H2BK5ac H2BK12ac H2BK15ac H2BK20ac sively at the ERV1 subfamily HERV-H H2BK120ac H3K4ac and its flanking LTR elements LTR7 (Fig- H3K9ac Histone H3K14ac ure 2D, bottom). Together, HERV-H and acetylation H3K18ac H3K23ac LTR7 account for more than 43% of H3K27ac H3K56ac LTRs that are present at H1- and ME-spe- H4K5ac cific lncRNA gene promoters. A gene H4K91ac H3K4me1 ontology analysis of coding genes near H3K4me2 H3K4me3 H1-specific HERV-H/LTR7 sites revealed Histone H3K27me3 an enrichment of POU5F1-targeted methylation H3K9me3 15 H3K36me3 genes (p value = 4 3 10À ), which is H4K20me1 H3K79me1 consistent with a previous study showing H3K79me2 mCG/CG that NANOG and POU5F1 preferentially RNA (+) bind to repetitive elements (Kunarso RNA (-) PPP1R10 DHX16 MDC1 IER3 DDR1 SFTA2 MUC21 HCG22 C6orf15 TCF19 HCG27 et al., 2010). We did not find significant PRR3 MRPS18B PPP1R18 TUBB DDR1 DPCR1 MUC22 PSORS1C1 ABCF1 ATAT1 NRM FLOT1 MIR4640 CDSN TCF19 MIR877 C6orf136 NRM GTF2H4 PSORS1C2 PPP1R10 DHX16 VARS2 CCHCR1 enrichment of LTR subclasses for other C6orf136 NRM POU5F1 PPP1R18 POU5F1 lineage-restricted lncRNA genes. Repeti- tive elements are known to be regulated by DNA methylation and H3K9me3 in Idea: We need a way to summarize the combinatorial paerns of NANOG, POU5F1, and a reduced but significant level of SOX2. ESCs (Leung and Lorincz, 2012). We do not find significant We then investigated a cohort of long noncoding RNA (lncRNA) enrichment of H3K9me3 around most HERV-H elements (data mul-ple histone marks genes and detected significant levels of transcripts for 2,175 not shown). By contrast, a7 subset of the H1-specific HERV-H known and 281 unannotated lncRNA genes in at least one cell elements (n = 70) show hypomethylation in H1 and ME but type (Figures 2A and S2A). Using the same entropy-based gain DNA methylation in other H1-derived cells (Figures 2B and approach, we found 930 lncRNA genes defined as lineage 2E). Notably, the overall low level of DNA methylation in IMR90 restricted (Figure S2C), which constitute 37.9% of total ex- reflects its globally hypomethylated genome, likely due to the pressed lncRNA genes. By contrast, only 16.5% of expressed presence of partially methylated domains (PMDs) (Figures S2E coding genes are characterized as lineage restricted (Fig- and S2F) (Lister et al., 2009).
Recommended publications
  • Functional Roles of Bromodomain Proteins in Cancer
    cancers Review Functional Roles of Bromodomain Proteins in Cancer Samuel P. Boyson 1,2, Cong Gao 3, Kathleen Quinn 2,3, Joseph Boyd 3, Hana Paculova 3 , Seth Frietze 3,4,* and Karen C. Glass 1,2,4,* 1 Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA; [email protected] 2 Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; [email protected] 3 Department of Biomedical and Health Sciences, University of Vermont, Burlington, VT 05405, USA; [email protected] (C.G.); [email protected] (J.B.); [email protected] (H.P.) 4 University of Vermont Cancer Center, Burlington, VT 05405, USA * Correspondence: [email protected] (S.F.); [email protected] (K.C.G.) Simple Summary: This review provides an in depth analysis of the role of bromodomain-containing proteins in cancer development. As readers of acetylated lysine on nucleosomal histones, bromod- omain proteins are poised to activate gene expression, and often promote cancer progression. We examined changes in gene expression patterns that are observed in bromodomain-containing proteins and associated with specific cancer types. We also mapped the protein–protein interaction network for the human bromodomain-containing proteins, discuss the cellular roles of these epigenetic regu- lators as part of nine different functional groups, and identify bromodomain-specific mechanisms in cancer development. Lastly, we summarize emerging strategies to target bromodomain proteins in cancer therapy, including those that may be essential for overcoming resistance. Overall, this review provides a timely discussion of the different mechanisms of bromodomain-containing pro- Citation: Boyson, S.P.; Gao, C.; teins in cancer, and an updated assessment of their utility as a therapeutic target for a variety of Quinn, K.; Boyd, J.; Paculova, H.; cancer subtypes.
    [Show full text]
  • Anti-MRPS18B Antibody
    D225370 Anti-MRPS18B antibody Cat. No. D225370 Package 25 μl/100 μl/200 μl Storage -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Product overview Description A n ti-MRPS18B rabbit polyclonal antibody Applications ELISA, WB, IHC Immunogen Fusion protein of human MRPS18B Reactivity Human Content 1 mg/ml Host species Rabbit Ig class Immunogen-specific rabbit IgG Purification Antigen affinity purification Target information Symbol MRPS18B Full name mitochondrial ribosomal protein S18B Synonyms PTD017; S18amt; C6orf14; HSPC183; MRPS18-2; HumanS18a; MRP-S18-2 Swissprot Q9Y676 Target Background Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S18P family. The encoded protein is one of three that has significant sequence similarity to bacterial S18 proteins. The primary sequences of the three human mitochondrial S18 proteins are no more closely reSlated to angoneach other than they are to the prok aryBiotic S18 proteins. tPseuedogenches corresponding to this gene are found on chromosomes 1q and 2q. Applications Immunohistochemistry Predicted cell location: Cytoplasm Positive control: Human tonsil Recommended dilution: 25-100 The image on the left is immunohistochemistry of paraffin-embedded Human tonsil tissue using D225370(MRPS18B Antibody) at dilution 1/55, on the right is treated with fusion protein.
    [Show full text]
  • Quantitative Proteomics Methods for the Analysis of Histone Post-Translational Modifications
    Université de Montréal Quantitative Proteomics Methods for the Analysis of Histone Post-translational Modifications par Nebiyu Ali Abshiru Département de Chimie Faculté des arts et des sciences Thèse présentée à la Faculté des études supérieures et postdoctorales en vue de l’obtention du grade de philosophiae doctor (Ph.D.) en chimie Septembre 2015 ©Nebiyu Ali Abshiru, 2015 i Résumé Les histones sont des protéines nucléaires hautement conservées chez les cellules des eucaryotes. Elles permettent d’organiser et de compacter l’ADN sous la forme de nucléosomes, ceux-ci representant les sous unités de base de la chromatine. Les histones peuvent être modifiées par de nombreuses modifications post-traductionnelles (PTMs) telles que l’acétylation, la méthylation et la phosphorylation. Ces modifications jouent un rôle essentiel dans la réplication de l’ADN, la transcription et l’assemblage de la chromatine. L’abondance de ces modifications peut varier de facon significative lors du developpement des maladies incluant plusieurs types de cancer. Par exemple, la perte totale de la triméthylation sur H4K20 ainsi que l’acétylation sur H4K16 sont des marqueurs tumoraux spécifiques a certains types de cancer chez l’humain. Par conséquent, l’étude de ces modifications et des événements determinant la dynamique des leurs changements d’abondance sont des atouts importants pour mieux comprendre les fonctions cellulaires et moléculaires lors du développement de la maladie. De manière générale, les modifications des histones sont étudiées par des approches biochimiques telles que les immuno-buvardage de type Western ou les méthodes d’immunoprécipitation de la chromatine (ChIP). Cependant, ces approches présentent plusieurs inconvénients telles que le manque de spécificité ou la disponibilité des anticorps, leur coût ou encore la difficulté de les produire et de les valider.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Evidence for Differential Alternative Splicing in Blood of Young Boys With
    Stamova et al. Molecular Autism 2013, 4:30 http://www.molecularautism.com/content/4/1/30 RESEARCH Open Access Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders Boryana S Stamova1,2,5*, Yingfang Tian1,2,4, Christine W Nordahl1,3, Mark D Shen1,3, Sally Rogers1,3, David G Amaral1,3 and Frank R Sharp1,2 Abstract Background: Since RNA expression differences have been reported in autism spectrum disorder (ASD) for blood and brain, and differential alternative splicing (DAS) has been reported in ASD brains, we determined if there was DAS in blood mRNA of ASD subjects compared to typically developing (TD) controls, as well as in ASD subgroups related to cerebral volume. Methods: RNA from blood was processed on whole genome exon arrays for 2-4–year-old ASD and TD boys. An ANCOVA with age and batch as covariates was used to predict DAS for ALL ASD (n=30), ASD with normal total cerebral volumes (NTCV), and ASD with large total cerebral volumes (LTCV) compared to TD controls (n=20). Results: A total of 53 genes were predicted to have DAS for ALL ASD versus TD, 169 genes for ASD_NTCV versus TD, 1 gene for ASD_LTCV versus TD, and 27 genes for ASD_LTCV versus ASD_NTCV. These differences were significant at P <0.05 after false discovery rate corrections for multiple comparisons (FDR <5% false positives). A number of the genes predicted to have DAS in ASD are known to regulate DAS (SFPQ, SRPK1, SRSF11, SRSF2IP, FUS, LSM14A). In addition, a number of genes with predicted DAS are involved in pathways implicated in previous ASD studies, such as ROS monocyte/macrophage, Natural Killer Cell, mTOR, and NGF signaling.
    [Show full text]
  • Sequences, Annotation and Single Nucleotide Polymorphism of The
    Nova Southeastern University NSUWorks Biology Faculty Articles Department of Biological Sciences 6-2008 Sequences, Annotation and Single Nucleotide Polymorphism of the Major Histocompatibility Complex in the Domestic Cat Naoya Yuhki National Cancer Institute at Frederick James C. Mullikin National Human Genome Research Institute Thomas W. Beck National Cancer Institute at Frederick Robert M. Stephens National Cancer Institute at Frederick Stephen J. O'Brien National Cancer Institute at Frederick, [email protected] Follow this and additional works at: https://nsuworks.nova.edu/cnso_bio_facarticles Part of the Genetics and Genomics Commons, and the Zoology Commons NSUWorks Citation Yuhki, Naoya; James C. Mullikin; Thomas W. Beck; Robert M. Stephens; and Stephen J. O'Brien. 2008. "Sequences, Annotation and Single Nucleotide Polymorphism of the Major Histocompatibility Complex in the Domestic Cat." PLoS ONE 7, (3 e2674): 1-17. https://nsuworks.nova.edu/cnso_bio_facarticles/773 This Article is brought to you for free and open access by the Department of Biological Sciences at NSUWorks. It has been accepted for inclusion in Biology Faculty Articles by an authorized administrator of NSUWorks. For more information, please contact [email protected]. Sequences, Annotation and Single Nucleotide Polymorphism of the Major Histocompatibility Complex in the Domestic Cat Naoya Yuhki1*, James C. Mullikin2, Thomas Beck3, Robert Stephens4, Stephen J. O’Brien1 1 Laboratory of Genomic Diversity, National Cancer Institute at Frederick, Frederick, Maryland,
    [Show full text]
  • MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
    Cell Stem Cell Article MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells Amy N. Abell,1,2,7,* Nicole Vincent Jordan,1,2,7 Weichun Huang,6 Aleix Prat,2,4 Alicia A. Midland,5 Nancy L. Johnson,1,2 Deborah A. Granger,1,2 Piotr A. Mieczkowski,2,3 Charles M. Perou,2,4 Shawn M. Gomez,5 Leping Li,6 and Gary L. Johnson1,2,* 1Department of Pharmacology 2Lineberger Comprehensive Cancer Center 3Department of Genetics and Carolina Center for Genome Sciences 4Department of Genetics 5Department of Biomedical Engineering and Curriculum in Bioinformatics and Computational Biology University of North Carolina School of Medicine, Chapel Hill, NC 27599-7365, USA 6Biostatistics Branch, National Institute of Environmental Health Sciences RTP, NC 27709, USA 7These authors contributed equally to this work *Correspondence: [email protected] (A.N.A.), [email protected] (G.L.J.) DOI 10.1016/j.stem.2011.03.008 SUMMARY berg, 2008). During development, EMT is responsible for proper formation of the body plan and for differentiation of many tissues Epithelial stem cells self-renew while maintaining and organs. Examples of EMT in mammalian development multipotency, but the dependence of stem cell prop- include implantation, gastrulation, and neural crest formation erties on maintenance of the epithelial phenotype is (Thiery et al., 2009). Initiation of placenta formation regulated unclear. We previously showed that trophoblast by trophoectoderm differentiation is the first, and yet most poorly stem (TS) cells lacking the protein kinase MAP3K4 defined, developmental EMT. maintain properties of both stemness and epithelial- The commitment of stem cells to specialized cell types requires extensive reprogramming of gene expression, involving, in part, mesenchymal transition (EMT).
    [Show full text]
  • 2020 Program Book
    PROGRAM BOOK Note that TAGC was cancelled and held online with a different schedule and program. This document serves as a record of the original program designed for the in-person meeting. April 22–26, 2020 Gaylord National Resort & Convention Center Metro Washington, DC TABLE OF CONTENTS About the GSA ........................................................................................................................................................ 3 Conference Organizers ...........................................................................................................................................4 General Information ...............................................................................................................................................7 Mobile App ....................................................................................................................................................7 Registration, Badges, and Pre-ordered T-shirts .............................................................................................7 Oral Presenters: Speaker Ready Room - Camellia 4.......................................................................................7 Poster Sessions and Exhibits - Prince George’s Exhibition Hall ......................................................................7 GSA Central - Booth 520 ................................................................................................................................8 Internet Access ..............................................................................................................................................8
    [Show full text]
  • Structural Basis for DEAH-Helicase Activation by G-Patch Proteins
    Structural basis for DEAH-helicase activation by G-patch proteins Michael K. Studera, Lazar Ivanovica, Marco E. Webera, Sabrina Martia, and Stefanie Jonasa,1 aInstitute of Molecular Biology and Biophysics, Department of Biology, Swiss Federal Institute of Technology (ETH) Zürich, 8093 Zürich, Switzerland Edited by Joseph D. Puglisi, Stanford University School of Medicine, Stanford, CA, and approved February 21, 2020 (received for review August 12, 2019) RNA helicases of the DEAH/RHA family are involved in many essential RNA bases are stacked in the RNA binding channel between a long cellular processes, such as splicing or ribosome biogenesis, where β-hairpin in RecA2 (β14 to β15 in hsDHX15/scPrp43; SI Appendix, they remodel large RNA–protein complexes to facilitate transitions Fig. S1) and a conserved loop in RecA1 (termed “Hook-turn”). to the next intermediate. DEAH helicases couple adenosine tri- This means that during progression into the open state, the phosphate (ATP) hydrolysis to conformational changes of their β-hairpin and two other RNA-binding patches in RecA2 (termed catalytic core. This movement results in translocation along RNA, “Hook-loop” and “motif V”; SI Appendix, Fig. S1) have to shift 1 which is held in place by auxiliary C-terminal domains. The activity nucleotide (nt) toward the 5′ end of the RNA. Thus, when the of DEAH proteins is strongly enhanced by the large and diverse RecA domains close back up, at the start of the next hydrolysis class of G-patch activators. Despite their central roles in RNA me- cycle, the RNA is pushed by 1 nt through the RNA channel.
    [Show full text]
  • “The Impact of ART on Genome‐Wide Oxidation of 5‐Methylcytosine and the Transcriptome During Early Mouse Development”
    “The impact of ART on genome‐wide oxidation of 5‐methylcytosine and the transcriptome during early mouse development” Dissertation zur Erlangung des Grades “Doktor der Naturwissenschaften” am Fachbereich Biologie der Johannes Gutenberg-Universität Mainz Elif Diken geb. Söğütcü geb. am 22.07.1987 in Giresun-TURKEY Mainz 2016 Dekan: 1. Berichterstatter: 2. Berichterstatter: Tag der mündlichen Prüfung: Summary Summary The use of assisted reproductive technologies (ART) has been increasing over the past three decades due to the elevated frequency of infertility problems. Other factors such as easier access to medical aid than in the past and its coverage by health insurance companies in many developed countries also contributed to this growing interest. Nevertheless, a negative impact of ART on transcriptome and methylation reprogramming is heavily discussed. Methylation reprogramming directly after fertilization manifests itself as genome-wide DNA demethylation associated with the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in the pronuclei of mouse zygotes. To investigate the possible impact of ART particularly on this process and the transcriptome in general, pronuclear stage mouse embryos obtained upon spontaneous ovulation or superovulation through hormone stimulation representing ART were subjected to various epigenetic analyses. A whole- transcriptome RNA-Seq analysis of pronuclear stage embryos from spontaneous and superovulated matings demonstrated altered expression of the Bbs12 gene known to be linked to Bardet-Biedl syndrome (BBS) as well as the Dhx16 gene whose zebrafish ortholog was reported to be a maternal effect gene. Immunofluorescence staining with antibodies against 5mC and 5hmC showed that pronuclear stage embryos obtained by superovulation have an increased incidence of abnormal methylation and hydroxymethylation patterns in both maternal and paternal pronuclear DNA compared to their spontaneously ovulated counterparts.
    [Show full text]
  • Pharmacodynamic Effects of Seliciclib, an Orally Administered
    Cancer Therapy: Clinical Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer Wen-Son Hsieh,4 Ross Soo,1Bee-Keow Peh,2 Thomas Loh,4 Difeng Dong,3 Donny Soh,5 Lim-SoonWong,3,5 Simon Green,6 Judy Chiao,6 Chun-Ying Cui,1Yo k e -F o n g L a i , 4 Soo-Chin Lee,1Benjamin Mow,1 Richie Soong,2 Manuel Salto-Tellez,2 and Boon-Cher Goh1, 2 Abstract Purpose: Cell cycle dysregulation resulting in expression of antiapoptotic genes and uncontrolled proliferation is a feature of undifferentiated nasopharyngeal carcinoma. The pharmacodynamic effects of seliciclib, a cyclin-dependent kinase (CDK) inhibitor, were studied in patients with nasopharyngeal carcinoma. Experimental Design: Patients with treatment-naI«ve locally advanced nasopharyngeal carci- noma received seliciclib at 800 mg or 400 mg twice daily on days1 to 3 and 8 to12.Paired tumor samples obtained at baseline and on day 13 were assessed by light microscopy, immunohisto- chemistry, and transcriptionalprofiling using real-time PCR low-density array consisting of apanel of 380 genes related to cell cycle inhibition, apoptosis, signal transduction, and cell proliferation. Results: At 800 mg bd, one patient experienced grade 3 liver toxicity and another had grade 2 vomiting; no significant toxicities were experienced in 13 patients treated at 400 mg bd. Seven of fourteen evaluable patients had clinical evidence of tumor reduction. Some of these responses were associated with increased tumor apoptosis, necrosis, and decreases in plasma EBV DNA posttreatment. Reduced protein expression of Mcl-1, cyclin D1, phosphorylated retinoblastoma protein pRB (T821), and significant transcriptional down-regulation of genes related to cellular proliferation and survival were shown in some patients posttreatment, indicative of cell cycle modulation by seliciclib, more specifically inhibition of cdk2/cyclin E, cdk7/cyclin H, and cdk9/cyclinT.
    [Show full text]
  • EIN2 Mediates Direct Regulation of Histone Acetylation in the Ethylene Response
    EIN2 mediates direct regulation of histone acetylation in the ethylene response Fan Zhanga,b,1, Likai Wanga,b,1, Bin Qic, Bo Zhaoa,b, Eun Esther Koa,b, Nathaniel D. Riggana,b, Kevin China,b, and Hong Qiaoa,b,2 aInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712; bDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712; and cDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309 Edited by Steven E. Jacobsen, University of California, Los Angeles, CA, and approved August 10, 2017 (received for review May 15, 2017) Ethylene gas is essential for developmental processes and stress of EBF1 and EBF2 (19, 20). In the nucleus, the EIN2-C transduces responses in plants. Although the membrane-bound protein EIN2 is signals to the transcription factors EIN3 and EIL1, which are key for critical for ethylene signaling, the mechanism by which the ethylene activation of expression of all ethylene-response genes (21, 22). We signal is transduced remains largely unknown. Here we show the recently discovered that acetylation at H3K23 and H3K14Ac is in- levels of H3K14Ac and H3K23Ac are correlated with the levels of volved in ethylene-regulated gene activation in a manner that de- EIN2 protein and demonstrate EIN2 C terminus (EIN2-C) is sufficient to pends on both EIN2 and EIN3 (23, 24). rescue the levels of H3K14/23Ac of ein2-5 at the target loci, using Here we show that the levels of H3K14/23Ac are positively CRISPR/dCas9-EIN2-C.
    [Show full text]